Exenatide is the worlds first GLP-RA product
Cagrilintide acts via amylin/calcitonin receptors (satiety, delayed gastric emptying), whereas Retatrutide is a triple GLP-1/GIP/glucagon agonist
Half-Life and Route GHRP-2 is a small peptide and, like most peptides, is not orally bioavailable in any efficient way because it is degraded in the gastrointestinal tract which is why parenteral (typically subcutaneous) administration dominates the research literature, and why intranasal delivery was explored in some early studies
Gastrointestinal side effects (nausea, vomiting, diarrhoea) affecting 2040% of patients may trigger autonomic sweating responses as a physiological stress reaction
That means it is generally taken for around 8 to 12 weeks
The primary aim of Ozempic is to help individuals with type 2 diabetes better manage their blood sugar levels, promote weight loss, and improve overall metabolic health